<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Malignancy</z:e>-related <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>, so-called <z:e sem="disease" ids="C0398359" disease_type="Disease or Syndrome" abbrv="">Trousseau's syndrome</z:e>, can present as <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, non-<z:mp ids='MP_0001794'>bacterial</z:mp> thrombotic <z:hpo ids='HP_0100584'>endocarditis</z:hpo> (NBTE) and migratory <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It is usually attributed to a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e>, <z:hpo ids='HP_0011010'>chronic</z:hpo> disseminated intravascular <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> (<z:chebi fb="0" ids="53092">DIC</z:chebi>), or <z:e sem="disease" ids="C0013930" disease_type="Neoplastic Process" abbrv="">tumour embolism</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We report on two patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the colon and <z:mpath ids='MPATH_354'>cholangiocarcinoma</z:mpath> who developed widespread <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> during disease progression </plain></SENT>
<SENT sid="3" pm="."><plain>Both did poorly despite aggressive institution of anticoagulation therapy </plain></SENT>
<SENT sid="4" pm="."><plain>These cases emphasize that <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> or refractory <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-treated patients should prompt investigation for recurrent or <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> or progression of the underlying <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Optimal treatment remains to be established </plain></SENT>
</text></document>